Cargando…
Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017
BACKGROUND: The point prevalence survey of healthcare-associated infections (HAIs) and antimicrobial use organized by the European Centre for Disease Prevention and Control (ECDC-PPS) and the Global Point Prevalence Survey of antimicrobial consumption (Global-PPS) were simultaneously performed in Be...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958935/ https://www.ncbi.nlm.nih.gov/pubmed/31956402 http://dx.doi.org/10.1186/s13756-019-0663-7 |
_version_ | 1783487500017205248 |
---|---|
author | Vandael, Eline Latour, Katrien Goossens, Herman Magerman, Koen Drapier, Nico Catry, Boudewijn Versporten, Ann |
author_facet | Vandael, Eline Latour, Katrien Goossens, Herman Magerman, Koen Drapier, Nico Catry, Boudewijn Versporten, Ann |
author_sort | Vandael, Eline |
collection | PubMed |
description | BACKGROUND: The point prevalence survey of healthcare-associated infections (HAIs) and antimicrobial use organized by the European Centre for Disease Prevention and Control (ECDC-PPS) and the Global Point Prevalence Survey of antimicrobial consumption (Global-PPS) were simultaneously performed in Belgian acute care hospitals in 2017. METHODS: Belgian acute care hospitals were invited to participate in either the ECDC or Global-PPS. Hospital/ward/patient-level data were collected between September–December 2017. All patients present in the wards at 8 a.m. on the day of the PPS were included. The data of the ECDC and Global-PPS on antimicrobial consumption were pooled. Detailed data on HAIs were analysed for ECDC-PPS. RESULTS: Overall, 110 Belgian acute care hospital sites participated in the ECDC and Global-PPS (countrywide participation rate: 81.4%, 28,007 patients). Overall, a crude prevalence of patients with at least one antimicrobial of 27.1% (95% confidence interval (CI) 26.5–27.6%) was found. The most frequently reported indications were pneumonia (23.2%), urinary tract infections (15.2%) and skin and soft tissue infections (11.9%). The reason for antimicrobial use was recorded for 81.9% of the prescriptions, a stop/review date for 40.8% and compliance with local antibiotic guidelines for 76.6%. In the ECDC-PPS, the crude prevalence of patients with at least one HAI was 7.3% (95%CI 6.8–7.7%). Most frequently reported HAIs were pneumonia (21.6%) and urinary tract infections (21.3%). CONCLUSIONS: HAI and antimicrobial use prevalence remained stable in comparison with the previous PPS (7.1% and 27.4% in 2011 and 2015, respectively). Belgian hospitals should be further stimulated to set local targets to improve antibiotic prescribing and reduce HAI. |
format | Online Article Text |
id | pubmed-6958935 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-69589352020-01-17 Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017 Vandael, Eline Latour, Katrien Goossens, Herman Magerman, Koen Drapier, Nico Catry, Boudewijn Versporten, Ann Antimicrob Resist Infect Control Research BACKGROUND: The point prevalence survey of healthcare-associated infections (HAIs) and antimicrobial use organized by the European Centre for Disease Prevention and Control (ECDC-PPS) and the Global Point Prevalence Survey of antimicrobial consumption (Global-PPS) were simultaneously performed in Belgian acute care hospitals in 2017. METHODS: Belgian acute care hospitals were invited to participate in either the ECDC or Global-PPS. Hospital/ward/patient-level data were collected between September–December 2017. All patients present in the wards at 8 a.m. on the day of the PPS were included. The data of the ECDC and Global-PPS on antimicrobial consumption were pooled. Detailed data on HAIs were analysed for ECDC-PPS. RESULTS: Overall, 110 Belgian acute care hospital sites participated in the ECDC and Global-PPS (countrywide participation rate: 81.4%, 28,007 patients). Overall, a crude prevalence of patients with at least one antimicrobial of 27.1% (95% confidence interval (CI) 26.5–27.6%) was found. The most frequently reported indications were pneumonia (23.2%), urinary tract infections (15.2%) and skin and soft tissue infections (11.9%). The reason for antimicrobial use was recorded for 81.9% of the prescriptions, a stop/review date for 40.8% and compliance with local antibiotic guidelines for 76.6%. In the ECDC-PPS, the crude prevalence of patients with at least one HAI was 7.3% (95%CI 6.8–7.7%). Most frequently reported HAIs were pneumonia (21.6%) and urinary tract infections (21.3%). CONCLUSIONS: HAI and antimicrobial use prevalence remained stable in comparison with the previous PPS (7.1% and 27.4% in 2011 and 2015, respectively). Belgian hospitals should be further stimulated to set local targets to improve antibiotic prescribing and reduce HAI. BioMed Central 2020-01-13 /pmc/articles/PMC6958935/ /pubmed/31956402 http://dx.doi.org/10.1186/s13756-019-0663-7 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Vandael, Eline Latour, Katrien Goossens, Herman Magerman, Koen Drapier, Nico Catry, Boudewijn Versporten, Ann Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017 |
title | Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017 |
title_full | Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017 |
title_fullStr | Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017 |
title_full_unstemmed | Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017 |
title_short | Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017 |
title_sort | point prevalence survey of antimicrobial use and healthcare-associated infections in belgian acute care hospitals: results of the global-pps and ecdc-pps 2017 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958935/ https://www.ncbi.nlm.nih.gov/pubmed/31956402 http://dx.doi.org/10.1186/s13756-019-0663-7 |
work_keys_str_mv | AT vandaeleline pointprevalencesurveyofantimicrobialuseandhealthcareassociatedinfectionsinbelgianacutecarehospitalsresultsoftheglobalppsandecdcpps2017 AT latourkatrien pointprevalencesurveyofantimicrobialuseandhealthcareassociatedinfectionsinbelgianacutecarehospitalsresultsoftheglobalppsandecdcpps2017 AT goossensherman pointprevalencesurveyofantimicrobialuseandhealthcareassociatedinfectionsinbelgianacutecarehospitalsresultsoftheglobalppsandecdcpps2017 AT magermankoen pointprevalencesurveyofantimicrobialuseandhealthcareassociatedinfectionsinbelgianacutecarehospitalsresultsoftheglobalppsandecdcpps2017 AT drapiernico pointprevalencesurveyofantimicrobialuseandhealthcareassociatedinfectionsinbelgianacutecarehospitalsresultsoftheglobalppsandecdcpps2017 AT catryboudewijn pointprevalencesurveyofantimicrobialuseandhealthcareassociatedinfectionsinbelgianacutecarehospitalsresultsoftheglobalppsandecdcpps2017 AT versportenann pointprevalencesurveyofantimicrobialuseandhealthcareassociatedinfectionsinbelgianacutecarehospitalsresultsoftheglobalppsandecdcpps2017 AT pointprevalencesurveyofantimicrobialuseandhealthcareassociatedinfectionsinbelgianacutecarehospitalsresultsoftheglobalppsandecdcpps2017 |